Jenning Voss
Optometrist · Afton, WYNPI 1811249154
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $941 of the $1,445 with a category attached, or 65.1%. Johnson & Johnson Vision Care, Inc. accounts for 81.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $1,250 and has fallen 94.3% since, to $71 in 2023. Among optometrist clinicians in WY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 16 payments — averaging $90.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$1K
- Alcon$67
- Lombart Brothers, Inc.$61
- Carl Zeiss Meditec, Inc.$49
- Coopervision Inc.$46
- LKC Technologies, Inc.$26
- plus $20 from 1 others
What the payments were for
- Travel & lodging$94165%
- Food & beverage$50535%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 7 | $1,178 |
| Alcon | 4 | $67 |
| Lombart Brothers, Inc. | 1 | $61 |
| Carl Zeiss Meditec, Inc. | 1 | $49 |
| Coopervision Inc. | 1 | $46 |
| LKC Technologies, Inc. | 1 | $26 |
| Bausch & Lomb Americas Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$1,051
How this compares
$1,445 in reported general payments places this provider in the 90th percentile of 102 optometrist providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CombiganBrimonidine Tartrate/Timolol | 12 | $2,310 |
| Latanoprost | 74 | $677 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 13 | $169 |
| Dorzolamide Hcl | 11 | $156 |
| Timolol Maleate | 15 | $113 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Afton
- Mark WellsCheyenne$251K
- David EldredCheyenne$177K
- Joseph MunsellCheyenne$5K
- Jason WhitmanCasper$4K
- Michelle ChaneyLaramie$4K
- Shelby ZemskiCheyenne$3K
- David BisbeeCheyenne$3K
- Ivan WhettenRock Springs$3K
- Jacee CottonCheyenne$2K
- Jessica AlbersCheyenne$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.